![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has four drugs on the market: Onpattro for hATTR amyloidosis, Givlaari fo... Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has four drugs on the market: Onpattro for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. The firm also has 12 clinical programs across the following therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Additionally, up-front fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships. Show more
MUSQ ETF TAKES CENTER STAGE AS ETC's NEWEST ENTERTAINMENT FUND PR Newswire NEW YORK, July 13, 2023 Exchange Traded Concepts Adds MUSQ to ETF Lineup NEW YORK, July 13, 2023 /PRNewswire/ -- The...
MUSQ Offers Investors a Front Row Seat to the Growing Music Industry MUSQ, LLC today announces the launch of the MUSQ Global Music Industry ETF (NYSE: MUSQ), a cutting-edge exchange-traded fund...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 31.41 | 13.241989882 | 237.2 | 271.005 | 232.2 | 960949 | 252.34875591 | CS |
4 | 21.66 | 8.77100627657 | 246.95 | 271.005 | 231.01 | 870852 | 249.20608363 | CS |
12 | 116.8 | 76.9382781108 | 151.81 | 271.005 | 144.73 | 1071254 | 213.09985214 | CS |
26 | 95.85 | 55.4815929613 | 172.76 | 271.005 | 141.975 | 925969 | 184.5808087 | CS |
52 | 81.48 | 43.5419227275 | 187.13 | 271.005 | 141.975 | 764120 | 182.06987827 | CS |
156 | 90.31 | 50.6505888951 | 178.3 | 271.005 | 117.58 | 786016 | 184.60133233 | CS |
260 | 193.66 | 258.385590394 | 74.95 | 271.005 | 67.55 | 731442 | 164.74025963 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions